SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 24.03-1.7%11:56 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bretsky who wrote (8151)7/20/1999 4:31:00 AM
From: John Carpenter  Read Replies (1) of 9523
 
My posts were arrogant. I apologize to the thread for
my brazen, mindless banter.

As per tripling in the next year, the only stocks that
have a chance are business to business E-commerce plays,
by virtue of the exponential growth in this area.
INIT , ARBA , and EXDS are good plays for capital appreciation.

Sure, PFE won't triple in the next year, but it's a lot
safer than INIT, ARBA, and EXDS. Along with higher potential
return comes risk. At least with PFE, you can hold on for the
long term, confident that its unrivaled R&D prowess will once
again pave the way for consistent, above average returns with
only moderate risk.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext